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Abstract
Receptor- and adsorptive-mediated transport through brain endothelial cells (BEC) of the blood-brain barrier (BBB)
involves a complex array of subcellular vesicular structures, the endo-lysosomal system. It consists of several types of
vesicles, such as early, recycling, and late endosomes, retromer-positive structures, and lysosomes. Since this system is
important for receptor-mediated transcytosis of drugs across brain capillaries, our aim was to characterise the endo-
lysosomal system in BEC with emphasis on their interactions with astrocytes. We used primary porcine BEC in
monoculture and in co-culture with primary rat astrocytes. The presence of astrocytes changed the intraendothelial
vesicular network and significantly impacted vesicular number, morphology, and distribution. Additionally, gene set
enrichment analysis revealed that 60 genes associated with vesicular trafficking showed altered expression in co-cultured
BEC. Cytosolic proteins involved in subcellular trafficking were investigated to mark transport routes, such as RAB25
for transcytosis. Strikingly, the adaptor protein called AP1-μ1B, important for basolateral sorting in epithelial cells, was
not expressed in BEC. Altogether, our data pin-point unique features of BEC trafficking network, essentially mapping
the endo-lysosomal system of in vitro BBB models. Consequently, our findings constitute a valuable basis for planning
the optimal route across the BBB when advancing drug delivery to the brain.
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Introduction
The brain endothelial cells (BEC)-based in vitro models are
one of the most versatile tools in blood-brain barrier (BBB)
research for testing drug penetration toward the central ner-
vous system [1, 2] or modelling pathological conditions [3].
The in vitro models have been particularly useful in studies of
subcellular trafficking of receptors and their cargos during
receptor-mediated transcytosis. Both receptor- and
adsorptive-mediated transcytoses involve the vesicular system
[1, 4–6] and are facilitated by cytosolic adaptor proteins [7]
(Fig. 1). Vesicular pathways play an important role in cell
physiology by influencing features such as signalling [8, 9],
polarity [10], cell junction formation, and maintenance [11].
Furthermore, in BEC, components of the endo-lysosomal sys-
tem are important players in receptor-mediated transcytosis of
pharmaceutical antibodies [6, 12]. However, the underlying
mechanisms are poorly understood. To optimise approaches
for drug delivery to the brain, it is important to characterise the
vesicular transport system in BEC.
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The BEC are coupled by constricting Btight junctions^ and
are highly polarised cells [13] similar to epithelial cells.
Therefore, their drug penetration properties [14] and subcel-
lular trafficking structures have been assumed to be similar to
those of epithelial cells [7]. Transport in epithelial cells uses a
complex subcellular vesicular system, the so-called endo-ly-
sosomal system (Fig. 1). This system consists of the trans-
Golgi network (TGN), several types of endosomal vesicle
such as early (EE), recycling (RE), late endosomes (LE),
retromer positive structures (RPS), as well as lysosomes. EE
are the main sorting stations in the endocytic pathway, receiv-
ing receptors and cargo from almost all types of endocytosis
[15]. The internalised membrane components and fluid are
recycled back to the surface via RE [16], whereas retrograde
receptors and certain ligands are retrograde transported to
TGN via RPS [17]. The remaining EE mature into LE and
finally into lysosomes [16]. Membrane fusion along these
pathways is mediated by membrane-bound protein complexes
known as soluble N-ethylmaleimide-sensitive factor attach-
ment protein receptors (SNAREs) [18]. Trafficking among
the structures of the endo-lysosomal system is guided by
Ras-related proteins (RAB) and specific adaptor proteins such
as the retromer complex [19], and the adaptins [20]. Different
isoforms of the heteromeric adaptin complex can facilitate cell
specific trafficking [20]. The retromer complex is composed
of a conservative cargo recognition subcomplex made of the
vacuolar protein sorting-associated proteins (VPS) forming a
VPS26-VPS29-VPS35 trimer and a domain composed of dif-
ferent dimers of sorting nexins (SNX) directing the transport
of the cargo [17].
To maintain and induce the specific in vivo observed BBB
characteristics, in vitro cultured primary BEC need signalling
factors from other cell types. One of the most important and
widely studied interactions is between BEC and astrocytes.
Since endothelial cells have a large repertoire of receptors
for astrocyte-released agents, a range of distinct and complex
responses of the endothelium has been observed [21]. Cross-
talk between these cells upregulates unique BBB features in
endothelial cells which results in the morphological [22] and
metabolic barrier properties [23–25] and unique patterns of
receptors and transporters [26] coupled with low permeability
for transcellular [27, 28] and paracellular permeability
markers [29] together with a high transendothelial electrical
resistance [22]. To induce these specific characteristics, sever-
al methods have been developed over time [3]. One of the
most commonly used techniques for primary models is to
co-culture BEC with astrocytes [29] and supplement the cul-
ture media with differentiation factors such as cyclic adeno-
sine monophosphate (cAMP) [22] and hydrocortisone [30]. In
addition to having BBB-differentiating effects on BEC


































Fig. 1 Vesicular transport in brain endothelial cells. Adsorptive- and
receptor-mediated transcytosis is often represented in a simple
Bstripped-down^ way. Since the inner part of eukaryotic cells is highly
compartmentalised, in reality transcytosis involves the complex endo-
lysosomal system. This system consists of trans-Golgi network (TGN),
several types of vesicles such as early (EE), recycling (RE), and late
endosomes (LE), retromer positive structures (RPS), and lysosomes. EE
are the main sorting stations in the endocytic pathway, receiving receptors
and cargo from almost all types of endocytosis. The internalised mem-
brane components and fluid are recycled back to the surface via RE,
whereas retrograde receptors and certain ligands are retrograde
transported to TGN via RPS. The remaining EE mature into LE and
finally into lysosomes. To facilitate receptor transport, different cytosolic
adaptor proteins (e.g. adaptins, retromer complex) are used by the cells
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themselves [31], these factors have been found to be necessary
to transmit BBB-inducing effects of astrocytes by regulatory
factors [32]. Given this background, we have chosen the dif-
ferentiated primary porcine BEC in monoculture and in co-
culture with rat astrocytes for our investigation. While the
effect of astrocytes on junctional proteins and the paracellular
permeability of BEC under physiological and pathological
conditions has been widely studied [21, 33, 34], less is known
about the transcellular permeability and vesicular transport
routes across these cells.
Subcellular structures of the endo-lysosomal system in
BEC (Fig. 1) are expected to play an important role in
receptor-mediated transcytosis of pharmaceutical antibodies,
but the brain endothelium-specific regulation of receptor traf-
ficking and transport routes has not been investigated so far.
Therefore, our aim was to investigate and characterise the
endo-lysosomal system and the expressed adaptor proteins
in primary porcine BEC. To obtain a better understanding of
the in vivo situation, where astrocytes interact with BEC, in-
tracellular pathways in monocultured and in co-cultured BEC
with primary astrocytes were studied.
Materials and Methods
Reagents
All chemicals and reagents were purchased from Sigma-
Aldrich (Rødovre, Denmark) unless otherwise indicated.
In Vitro BBB Model Constructions
Isolation of primary rat astrocytes and porcine brain
microvessels was carried out as described in details in the
earlier published protocol by our laboratory [35]. Briefly, cul-
tures of glial cells were prepared from newborn Wistar rats.
Meninges were removed; the cortical pieces were mechanical-
ly dissociated, plated in poly-L-lysin-coated dishes, and kept
for minimum 3 weeks in DMEM containing 50-μg/ml genta-
micin and 10%FBSbefore being frozen.Minimumof 2weeks
before co-culture, astrocytes were thawed and grown as above
described in 12-well plate. Once the astrocytes reached 100%
confluence, the medium was changed every 3 days. In conflu-
ent glia cultures, at least 90% of cells were immunopositive
for glial fibrillary acidic protein (GFAP).
Following isolation, porcine brain capillaries were plated in
T75 flasks (Thermo Fisher Scientific, Roskilde, Denmark)
coated with collagen IV (500 μg/ml) and fibronectin
(100 μg/ml) in DMEM/F12 medium supplemented with
10% plasma-derived bovine serum (PDS; First Link Ltd.,
Wolverhampton, UK), basic fibroblast growth factor (1 ng/
ml), heparin (15 U), insulin-transferrin-selenium, and genta-
micin (5 μg/ml) and cultured in a humidified incubator
with 5% CO2 at 37 °C. Puromycin (4 μg/ml) was added to
the medium for the first 3 days to obtain a pure culture of BEC
and remove contaminating cells. Cells were grown until 70%
confluency then passaged onto 1.12-cm2 polycarbonate cul-
ture inserts with 0.4-μm pore size (Costar, Corning,
Kennebunk, ME, USA) at a density of 1–2 × 105 cells/cm2.
Three different groups were used in this study; namely the
control BEC (i), differentiated BEC (ii), and co-cultured BEC
(iii) (Fig. S1a). In the control condition (i), BEC did not re-
ceive any further treatment. In the differentiated (ii) and co-
cultured (iii) groups, when the BEC had reached confluence—
approximately 1 or 2 days after seeding—the medium was
supplemented with differentiation factors; 550-nM hydrocor-
tisone, 250-μM 8-(4-chlorophenylthio)adenosine-3′,5′-cyclic
monophosphate (cAMP), and 17.5-μM RO-201724. BEC
treated with differentiation factors and grown in monoculture
are referred to later as differentiated BEC (ii). In the third
group (iii), BEC were kept in a non-contact co-culture with
rat astrocytes on the bottom of the 12-well culture dish from
the following day after seeding them on insert. When the BEC
had reached confluence, approximately 2 days after co-cul-
ture, the media on BEC and astrocytes have been changed
and were supplied with the above-mentioned differentiation
factors daily. Sample collection was carried out 2 days after
supplementing the media with differentiation factors. At this
time points, the models were validated by measuring
transendothelial electrical resistance. The obtained value for
control (80 ± 3.5 Ω × cm2), for differentiated monoculture
(513 ± 22.91 Ω × cm2) and for co-culture (914 ± 38.66
Ωxcm2), was in the range of previously described data from
other groups [36–38].
Antibodies
Antibodies used for immunocytochemistry and Western blot
are listed in Table S1. The specificity of the antibodies for
porcine BEC was confirmed by Western blot of whole cell
lysates (Fig. S2). The junctions of BEC were marked with
antibodies against adherens junction protein p120 catenin or
against tight junction protein ZO1. All antibodies are commer-
cially available and have previously been used as specific
markers.
Immunofluorescence Staining and Confocal
Microscopy
Cells were fixed with 4% paraformaldehyde in PBS or for
RAB7 staining with methanol for 10 min at − 20 °C.
Permeabilisation and blocking were done with 0.3% Triton-
X100 and 1% bovine serum albumin in PBS. Primary anti-
bodies were diluted 1:300 in blocking solution and incubated
with the samples for 1 h at RT. Samples were treated with
secondary antibodies at 1:400 dilutions for 1 h at RT. For
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staining of the nuclei, samples were incubated with Hoechst
32528 in distilled water (0.5 μg/ml). The filters supporting the
cells were cut out and mounted on glass slides using Dako
fluorescence mounting medium (Dako, Glostrup, Denmark).
Confocal images were captured by Olympus IX-83 fluores-
cent microscope with Andor confocal spinning unit and
Andor iXon Ultra 897 camera, Olympus Upsalo W, ×60/
1.20 NA water objective lens, using Olympus CellSens soft-
ware (Olympus). Images were processed using Fiji software.
For each channel, brightness and contrast adjustments were
applied independently.
High Content Screening Analysis
Cells for high content screening were passaged as well onto
1.12-cm2 polycarbonate culture inserts with 0.4-μm pore size
and cultured as described above. Images were obtained with
the Olympus automated Scan^R high content imaging station
based on the Olympus BX73 microscope, with a ×60/0.9 NA
air objective, triple-band emission filter for Hoechst 33258,
Alexa-Fluor-488 and Alexa-Fluor-568, and a Hamamatsu
camera (C8484-05G). Image analysis was performed using
Scan^R image and data analysis software for Life Science
(Münster, Germany) as described previously [39, 40].
Briefly, single-layer images were background-corrected and
edge-detection algorithm was applied to segment subcellular
structures based on detection of gradient intensities of the
chosen colour channel. In this study, for identifying the differ-
ent subcellular structures, Hoechst 33258 for nuclei, Alexa-
Fluor-568 for junctions, and Alexa-Fluor-488 for vesicles
were used. Subcellular structures were independently selected
using the following criteria: if a closed connecting line (edge)
can be drawn around them and their area is larger than
0.05 μm2, the object is segmented. Objects are recognised
and selected, independent of their shape. Images with artefacts
or out of focus were manually gated out. The total number of
vesicles was normalised to the number of nuclei or area of the
junctions before making comparison among the adjacent
groups. The distance between the objects was determined by
applying Pythagoras’ theorem on x, y coordinate values of the
object’s border. Based on the distance from the nucleus and
the junctions, different zones were defined inside the cells
(Fig. S1b, c, d). Above the nuclei and 1 μm aroundwas named
Bperinuclear zone.^ Between 1 and 2 μm away from the nu-
cleus was defined as Bmiddle zone^ of the cell. The remaining
part was the processes of the cell. Since the interaction be-
tween BEC is highly important in maintaining the barrier,
we investigated the junctions and 1 μm around them. In the
present study, this part is defined as the Bjunctional zone.^ As
endothelial cells are attached to each other all along the edges
of the cells, the junctional zone overlaps partly with the other
above-mentioned zones. Number, area, and morphology of
vesicles from at least 1000 cells for each group and each
experiment (three experiments in triplicate) were detected
and analysed.
Western Blot
For Western blot, BEC were cultured in T75 flasks or co-
cultured with astrocytes on 75-mm diameter polycarbonate
Transwell inserts (Costar, Corning) in the above-described
manner. BEC were washed with PBS and lysed in ExB lysis
buffer (150-mM NaCl, 20-mM MgCl2, 20-mM CaCl2, 100-
mM HEPES, 1% TritonX-100, cOmplete™ protease inhibi-
tor). 2.3 μg of each protein sample was loaded on a 4–12%
polyacrylamide gel (NuPage, Thermo Fisher Scientific) and
subsequently transferred to nitrocellulose membrane. Before
incubating with primary antibodies (1:1000) overnight at
4 °C, the membrane was blocked in 5% skimmed milk,
0.01-M Tris-HCl, 0.15-M NaCl, and 0.1% Tween 20, pH
7.6 in buffer solution. Secondary HRP-conjugated antibodies
(1:2000) were applied for 1 h at room temperature. Finally,
bands were detected with using ECL (GE Healthcare) or
SuperSignal (Thermo scientific, Rockford, USA) according
to the manufacturer’s recommendations and visualised using
LAS 4000 (Fujifilm). For the complete list of antibodies used
in this study, see Table S1.
Next Generation Sequencing (NGS) Data Analysis
Total RNA was extracted from porcine microvascular BEC
kept in monocultures and in co-cultures with astrocytes using
the PicoPure RNA Isolation Kit (Arcturus Bioscience Inc.,
Mountain View, CA, USA). RNA was reverse transcripted
to cDNA and subjected to linear amplification using the
Ovation® RNA-Seq System V2 kit (NuGEN Inc., San
Carlos, CA, USA). Finally, RNA-seq libraries were construct-
ed using Illumina TruSeq DNA Sample and Preparation kit
(Illumina, San Diego, CA, USA) according to the manufac-
turer’s protocol. The integrity of libraries was validated using
Agilent Bioanalyzer 2100 and library yield was determined by
KAPA qPCR measurement. Sequencing was performed on an
Illumina HiSeq2000 platform (Illumina) with five random
samples per lane (AROS Applied Biotechnology). The raw
reads reported for each sample were aligned to the
ENSEMBL porcine reference using BTophat2^ [41]. The
number of reads mapping to each genomic feature (i.e. genes)
was determined using HTSeq (htseq-count) [42]; the count
method used was Bunion.^ This measure was used as a quan-
titative estimate of the expression levels of features. Count-
based differential expression analysis (DE) was done for the
samples using DESeq2 [43]. The expression ratios are repre-
sented on the alternative transformation of logarithm base 2
[44]. Gene set enrichment analysis was performed on those
genes that displayed significant (adjusted p ≤ 0.05) differential
expression using GSEA software [45] and Kyoto
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Encyclopedia of Genes and Genomes (KEGG) pathway anal-
ysis [46], in order to determine underlying biological themes
and pathways.
Validation of NGS Results with qPCR Analysis
Total RNA was extracted from the samples as described
above. Primers were designed using an exon-spanning ap-
proach when possible using the NCBI Primer BLAST
(https://www.ncbi.nlm.nih.gov/tools/primer-blast/). Selection
of genes for qPCR verification was performed using the
statistical algorithm NormFinder [47] to define a stability
value for key reference genes based on the NGS data
(Table S2). In this study, total RNA (25 ng) from each sample
was used as input to an RNA amplification step using theWT-
OvationTM PicoSLWTA System A (NuGEN Technologies,
Inc., CA, USA) including both oligo d(T) and random
hexamers for cDNA amplifications, and 100-ng cDNA was
used in each SYBR green (Roche, Hvidovre, Denmark) qPCR
reaction. Real-time quantitative PCR (RT-qPCR) was per-
formed using Brilliant SYBR Green Master Mix (Roche).
The PCR reactions were run in the Roche LightcyclerR96
(Roche) with the following protocol: 10-min DNA polymer-
ase activation at 95 °C, 45 cycles of 10-s denaturation at
95 °C, 10-s annealing at 60–66 °C (gene specific), and exten-
sion at 72 °C for 10 s, followed by a final denaturation step
until 95 °C over 5 min. Experiments were repeated at least
three times, each in three technical repeats. The expression
value of each gene relative to the reference gene (ACTB)
was calculated using ΔΔCT methods [48]. As a negative
control, cDNA from no template RT-qPCR reactions was
used. For each primer pair (Table S2), a dilution curve was
generated and only primer pairs with efficiency of 80–100%
were included.
Statistical Analysis
All data presented are means ± SEM. Values were compared
using one-way ANOVA followed by Tukey’s multiple com-
parison post hoc tests using GraphPad Prism 6.0 software
(GraphPad Software Inc., San Diego, CA, USA). Where only
two variables were compared, unpaired t test with Welch’s
correction analysis was applied. Statistical analysis for NGS
analysis is described above. Changes were considered statis-
tically significant at p ≤ 0.05. All experiments were repeated at
least three times; the number of parallel samples for each
experiment was at least three.
Results
To classify and quantify the different types of vesicles (Fig. 1),
early endosome antigen 1 (EEA1) was targeted as a specific
marker for EE [49], transferrin receptor (TfR) for RE [50],
Ras-related protein 7 (RAB7) for LE [51], lysosomal-
associated membrane protein 1 (LAMP1) for lysosomes
[52], and VPS35 for the RPS [19] (Fig. 2). These markers
are all standard markers for the given vesicular structures but
do not necessarily have functions in vesicular receptor traf-
ficking, like TfR and Lamp1.
Number of Vesicles
By applying the above-mentioned vesicle markers and
analysing the result by high content screening microscopy,
we were able to investigate the number of different types of
vesicle. Data from differentiated and co-cultured BEC were
normalised to the control (Fig. 3). Co-cultured BEC displayed
upregulation in the numbers of EE and RPS and downregula-
tion in the RE and LE. Changes in the differentiated BEC
showed the same trend as observed in the co-cultured group
but were significant only in the case of RPS compared to the
control. The influence of astrocytes was investigated by com-
paring the differentiated BEC to the co-cultured group.
Significant differences in the numbers of EE, RE, and LEwere
found. Interestingly, the number of lysosomes was not influ-
enced significantly in any of the groups.
In order to see which part of the BEC is particularly affect-
ed by the changes, we investigated the number of vesicles in
different zones of the cells (Table 1) related to their position
from the nucleus and the junctions (Fig. S1b) and normalised
to the control. The size of the nuclei (area 106.61 ± 0.3 μm2;
diameter 11.65 ± 0.5 μm) and the outlined junctional area
(147 ± 0.07 μm2) did not vary significantly among the differ-
ent groups. An elevated number of EE could be observed in all
zones of the cell, however, only significantly in the middle
zone and in the processes. The increase observed in co-culture
reached almost 30% in the middle zone and more than 50% in
the processes (Table 1). Decrease in RE was generally ob-
served in all zones of co-cultured cells to about the same
extent as in Fig. 3 (Table 1). The most dramatic change could
be seen in the processes and in the junctional zone. The num-
ber of LE dropped significantly in all zones of the cells but
predominantly near the junctions (Table 1). The increase in
RPS peaked in the processes in both groups. Although the
total number of lysosomes did not change substantially
(Fig. 3), we could see a significant peak in the processes of
co-cultured BEC (Table 1). These results indicate that astro-
cytes do not affect the total number of lysosomes but may
influence their number in different subcellular zones, i.e. re-
distribute them inside BEC.
Subcellular Distribution of the Vesicles
Subcellular redistribution of the vesicles even without affect-
ing their total number inside the cells may indicate altered
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physiological function [53]. Therefore, the proportion of spe-
cific vesicle types in the subcellular zones was calculated rel-
ative to their own total number/cell (100%) and then com-
pared among the groups (Fig. 4). Generally, about 20–25%
of the EE, RE, lysosomes, and RPS were located near the
nucleus, more than 35% in the middle zone and the rest (~
40%) in the processes (Fig. 4a, b, d, e). By contrast, the dis-
tribution of LE was the reverse (Fig. 4c); the majority of the
vesicles were located near the nucleus (~ 35%) and the middle
zone (~ 40%), with the lowest amount in the processes of
BEC. Generally, about one third of the vesicles could be found
in the junctional zone (Fig. 4f). The highest number of vesicles
near the junctions was observed for RE and RPS in all groups.
Examining the distributional differences among the
groups, treatment with differentiation factors and co-
culture with astrocytes affected the distribution of all
types of vesicles (Fig. 4), with the exception of RE
(Fig. 4b). We could see a shift in distribution of EE
toward the processes in co-cultured BEC. Distribution of
EE proved to be significantly different compared also to
the differentiated BEC (Fig. 4a). A similar trend was ob-
served for lysosomes and RPS; redistribution was signif-
icant compared to the control, but not between differenti-
ated and co-culture group (Fig. 4d, e). On the contrary to
the other type of vesicles, LE moved from the middle
toward the nucleus of the differentiated and co-cultured
BEC (Fig. 4c) and their number in the junctional zone of
co-cultured BEC decreased significantly compared to the
control (Fig. 4f).
Morphological Alteration of the Vesicles: Shape
and Area
Since not only the amount of vesicles but also their size and
shape can vary greatly [11, 54], we investigated their area and
circularity factor (CF) in different zones of the BEC (Fig. 5).
Fig. 2 Immunofluorescence
staining against endosomal
markers in control, differentiated,
and in co-cultured BEC in vitro.
Immunostaining for vesicles is
represented with green and for
cell border marker p120 catenin
with red. Nucleus is marked with
blue (Hoechst 33342). Specific
markers: for early endosomes
EEA1 (early endosome antigen
1), for recycling endosomes TfR
(transferrin receptor) for late
endosomes RAB7 (Ras-related
protein 7), for lysosomes LAMP1
(lysosomal-associated marker
protein 1), and for the retromer
positive structures VPS35
(vacuolar protein sorting-
associated protein 35) are
indicated with green on the
images. Magnification is ×60.
Scale bar: 10 μm
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The shape of the investigated vesicles (CF = 1.05–1.2) was
generally irregular compared to a perfect circular shape
(CF = 1.00).
As shown above, co-culture with astrocytes causes similar
changes in the number of EE and RPS (Fig. 3, Table 1).
Consistently, we find that astrocyte-induced changes in shape
and area of EE and RPS were similar (Fig. 5a, b, i, j). A
pronounced effect of astrocytes on CF was observed in the
processes of co-cultured BEC, while only minor changes were
seen in the remaining zones of the cells (Fig. 5a, i). On the
other hand, the area of these vesicles was reduced significantly
near the junctions, while being close to constant in the other
parts of the cells (Fig. 5b, j). For the RE, treatment of BEC
with differentiation factors and the presence of astrocytes af-
fected the shape and the size of the vesicles in all zones of the
cells (Fig. 5c, d). The CF and the vesicular area were reduced
significantly compared to the control, but there was no signif-
icant difference between the differentiated and the co-cultured
BEC. LE did not show remarkable variation in shape or area
among the groups (Fig. 5e, f). Generally, the area of LE
showed a tendency of decrease, as they were located further
away from the nucleus (Fig. 5f). By contrast, the shape of
lysosomes became even more irregular in the differentiated
and co-cultured BEC compared to the control (Fig. 5g).
Lysosomes also displayed the largest variation in size among
all types of vesicle (Fig. 5h).
Expression of Specific Trafficking Route-Related
Genes and Proteins
Based on the observed changes in vesicular features, including
size, shape, and subcellular distribution, we wanted to address
potential underlying changes in gene and protein expression
(Fig. 6a–c). We therefore determined the expression profiles
of trafficking-related genes in BEC after co-culturing them
with astrocytes (Table S3 and Fig. S3). Gene set enrichment
analysis showed that 22 genes encoding lysosomal proteins
and nine genes of membrane fusion mediating SNARE com-
plexes had altered expression in co-cultured BEC (Table S4).
Furthermore, distinctive expression of 29 genes involved in
endocytosis and endosomal maturation had a significant im-
pact on the endosomal part of vesicular transport. In order to
show functional relevance of changes in the endo-lysosomal
structure, we investigated the protein ratio of phosphorylated
ERK1/2 (pERK1/2) and ERK1/2 (Fig. 6c). We found that
pERK was significantly downregulated in co-cultured BEC
in accordance with the altered number of late endosomes
(Fig. 2). Additionally, the gene set enrichment analysis has
Fig. 3 Change in the number of
vesicular structures normalised to
control (100%). Values are
represented as mean ± SEM, n =
9. Statistical analysis; difference
was analysed by one-way
ANOVA followed by Tukey’s
post hoc test. Values were
considered statistically significant
at * p ≤ 0.05, ** p ≤ 0.01, *** p ≤
0.001 compared to the control and
at # p ≤ 0.05 ## p ≤ 0.01, ### p ≤
0.001 between the differentiated
and co-cultured BEC. ns; not
significant
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indicated that the MAPK pathway is significantly altered is
co-cultured BEC (Table S4).
In order to investigate these changes in detail, we focused
here on selected genes of cytosolic adaptor proteins essential
for specific transport routes. Adaptors for retrograde transport
include the heteropentameric retromer complexes [19]. We
found the mRNA level of the retromer subunits in BEC were
influenced by astrocytes (Fig. 6a and Table S3). Focusing on
the variable SNX-BAR subunits, we observed significant
changes in the SNX1, SNX2, SNX5, and SNX6 genes
(Fig. 6a). As retromer complexes can be regulated post-tran-
scriptionally, we examined the protein level of SNX1 and
SNX6 (Figs. 6b and S4), representing one of the two most
common paring options in the SNX-BAR complex (SNX1/2
and SNX5/6) [55]. SNX1 could be detected only in co-
cultured samples at a low level (Fig. 6b). Interestingly, the
protein level of SNX6 (Fig. 6b) and the number of SNX6-
positive structures (Fig. 6d, e) decreased prominently in dif-
ferentiated and co-cultured BEC, while the total number of
RPS marked by the non-exchangeable core protein VPS35
was significantly increased (Figs. 3 and 6e).
In the NGS data set, moderate downregulation of expres-
sion of the transcytotic vesicular marker RAB25 could be ob-
served (Table S3). However, at protein level, we did not detect
any clear difference among the groups (Figs. 6b and S4).
Among the average copy number of adaptin gene transcript
(AP average), AP2 was expressed at the highest level, follow-
ed by AP1, AP3, AP5, and AP4 (Fig. S3). The expression ratio
of transcripts encoding the AP1–4 subunits in co-cultured
BEC was similar to the level previously described in HeLa
cell line [56]. AP1 and AP3 have cell-specific μ subunits
(AP1M2 and AP3M2) [57]. We performed NGS and RT-
qPCR analysis for these specific mRNAs. The epithelial-spe-
cific, basolateral sorting-related AP1M2 was not expressed,
but the previously known as neuron-specific AP3M2 was
present in BEC (Fig. 6a and Table S3). The specificity of
AP1M2 PCR primer was confirmed on porcine kidney epithe-
lial tissue (Fig. 6a).
Discussion
Our study describes and classifies the endo-lysosomal system
in BEC using a set of standard vesicular markers and investi-
gates expression of selected trafficking-related genes and pro-
teins known to be involved in endocytosis, polarised sorting,
and transcytosis. Characterisation of the transport system in
BEC is important for better understanding of the cellular
mechanisms and trafficking routes used by receptor- or
adsorptive-mediated drug delivery. We focused particularly
Table 1 Subcellular changes in
the amount of vesicles. Number
of vesicles was normalised to
control (100%). All values are
expressed as mean ± SEM, n =
12. Differences were analysed by
one-way ANOVA followed by
Tukey’s post hoc test. Values
were considered statistically
significant at * p ≤ 0.05, ** p ≤
0.01, *** p ≤ 0.001 compared to
the control. ns; not significant
Number of vesicles per cell—compared to control (%)
Differentiated BEC Co-cultured BEC
Mean SEM p Mean SEM p
Early endosomes (EE) Perinuclear zone 1.11 8.91 ns 5.23 8.45 ns
Middle zone 10.21 10.90 ns 28.55 9.57 *
Processes zone 28.49 17.11 ns 53.32 17.11 *
Junctional zone 1.87 20.76 ns 19.52 19.70 ns
Recycling endosomes (RE) Perinuclear zone − 9.65 7.86 ns − 29.90 7.03 **
Middle zone 4.61 9.96 ns − 20.48 9.66 ns
Processes zone − 23.21 9.66 ns − 37.02 8.14 ***
Junctional zone − 26.74 9.30 * − 44.91 8.70 **
Late endosomes (LE) Perinuclear zone − 2.89 3.82 ns − 25.59 3.87 ***
Middle zone − 5.88 5.57 ns − 44.38 5.47 ***
Processes zone − 6.65 11.67 ns −43.98 11.67 **
Junctional zone − 23.04 8.62 * −58.94 8.37 ***
Lysosomes Perinuclear zone − 10.05 9.87 ns 3.31 11.58 ns
Middle zone 6.77 8.93 ns 9.94 9.84 ns
Processes zone 13.72 7.26 ns 30.19 9.10 **
Junctional zone − 13.50 14.20 ns − 15.48 13.58 ns
Retromer positive structures (RPS) Perinuclear zone 3.83 1.15 ns 1.53 2.76 ns
Middle zone 8.62 1.31 ns 7.14 2.26 ns
Processes zone 30.60 5.82 * 32.75 4.74 *
Junctional zone 2.82 3.26 ns − 0.31 3.42 ns
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on interactions between BEC and astrocytes, since co-cultured
BEC maintain the differentiated phenotype of receptors and
transcytosis more closely resembling the in vivo condition
[58, 59]. Our findings confirm and extend previous studies
on involvement of astroglia in vesicular trafficking of BEC,
where astrocytes are reported to lower transcellular permeabil-
ity of the BBB by 70% as confirmed in vitro [27] as well as
also in vivo [28]. However, hypoxic astrocytes increase pino-
cytotic vesicle production of BEC [60]. Interestingly, BEC-
derived extracellular vesicles can be taken up by astrocytes
[61]. In our co-culture model, we found that astrocytes affect-
ed genes involved in endocytosis, endosomal maturation, and
membrane fusion-related gene expressions (Table S4) elevat-
ed the number of EE and RPS, while both RE and LE declined
to the same extent (Fig. 3). These data suggest that astrocytes
influence the endosomal maturation process and vesicular
trafficking of BEC. Our work did not aim to give absolute
numbers of vesicles or trafficking-related proteins; rather, we
highlighted their fold changes. We focused on horizontal
differences inside the cells in vitro, because trafficking events
are highly influenced by the position of TGN near the nucleus
[11]. Furthermore, BEC fulfil their physical barrier function
by having tight intercellular junctions [62]. Therefore, it is
also important to investigate trafficking events near the junc-
tions. Our study has provided a horizontal map of the endo-
lysosomal system in BEC, which can serve as a basis for a
better understanding of intracellular trafficking in BEC.
In addition to the number, we investigated the shape, area,
and distribution of vesicles in BEC. Unlike in other cell types
[11], we observed the shape of these vesicles to be irregular
rather than round (Fig. 5). This may be partly due to the fact
that BEC are flat, elongated cells [14]. EE receive cargo from
all types of endocytosis and therefore they are localised main-
ly in the peripheral cytoplasm [63], as observed also in our
BEC (Fig. 4a). By increasing the number of EE (Fig. 3), even
more endosomes gathered in the processes of co-cultured
BEC. In addition to EE, RE has an important sorting function
in polarised cells by delivering membrane components to the
Fig. 4 Subcellular distribution of
vesicular structures. Subcellular
values are expressed as a
percentage of the total
intracellular vesicles for each
types and presented as mean, n =
9. Statistical analysis; difference
was analysed by one-way
ANOVA followed by Tukey’s
post hoc test. Values were
considered statistically significant
at * p ≤ 0.05, ** p ≤ 0.01, *** p ≤
0.001 compared to the control
(Cont) and at # p ≤ 0.05 between
the differentiated (Diff) and co-
cultured BEC (Co). ns; not
significant
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appropriate place via separate transport routes. Consequently,
RE can be considered as polarised vesicles with different
shapes and adaptor protein composition [64]. The number,
shape, and size of RE in BEC were strongly affected by as-
trocytes and differentiation factors (Figs. 1 and 4 and Table 1),
indicating that polarity induction in BEC happens also at the
level of RE. Unlike other endosomes, LE were located dom-
inantly in the perinuclear zone (Fig. 4c), where they are able to
fuse with each other as well as with lysosomes [65]. However,
the number of LE decreased in co-cultured BEC (Fig. 3), with
fewer lysosomes located near the nucleus and more in resting
state in the processes of these cells (Fig. 4d). Interestingly,
astrocytes did not affect the number of lysosomes in BEC
(Fig. 3), but astrocytes did affect BEC’s gene expression im-
portant for transport and synthesis of lysosomal enzymes
(Table S4). Since the endosomes and lysosomes are responsi-
ble for regulation and fine-tuning of numerous pathways in
the cell [8, 9], the idea that astrocytes induce some BBB
endosomal properties by altering the endothelial endo-
lysosomal system appears likely.
Furthermore, endosomes are also signalling platforms
to ensure correct signal decoding in pathways like the
mitogen-activated protein kinases (MAPK/ERK) path-
ways [9, 66]. This pathway is involved in transcytosis
regulation in BEC [67] as well as astrocytes [27, 28]. In
this signalling pathway, mitogen-activated protein kinase
1 (MEK1) promotes the activation and phosphorylation of
ERK1 and ERK2 kinases [68], which is localises to the
late endosomal membrane [68, 69]. We found that the
level of phosphorylated ERK1/2 was significantly down-
regulated (Fig. 6c) in co-cultured BEC along with the
decreased number of late endosomes (Fig. 3). Based on
these observations, we speculate that astrocytes might
modulate these signalling pathways also via the endo-
lysosomal system to induce and maintain BBB properties
of BEC. Further experiments are needed to reveal the
exact functional changes in BEC resulting from the sig-
nalling pathway modulating action of vesicles. In summa-
ry, we have shown that astrocytes affected not only the
number of endothelial vesicles but also influenced their
shape, area, distribution, and the endo-lysosomal system-
related gene expression specifically.
To further investigate trafficking-related differences in-
duced by astrocytes, we examined gene expression of BEC
to pinpoint alteration with potential implication on the change
in vesicular features. For transcytosis, RE are guided by
RAB25 from the apical to the basolateral membrane in
polarised epithelial cells [70, 71]. In our study, astrocytes
moderately decreased the gene expression (Table S3) of this
adaptor protein. At protein level, we confirmed the presence
of RAB25 in BEC, but we could not detect significant differ-
ences among the groups (Fig. 6b). Fine-tuning of RAB25 is
necessary for proper transcytosis. Silencing of RAB25 gene
inhibits transcellular transport in both directions [70], but
overexpression of its protein also decreases transcytosis from
the apical membrane [71].We suggest that RAB25 can also be
an important regulator of transcytosis in BEC. Further exper-
iments needed to confirm its precise role and regulation in
these cells. In the transcytotic machinery of polarised epithe-
lial cells, the retromer, another important adaptor protein com-
plex, is involved [72]. This complex is essential for the retro-
grade transport route from EE and LE toward TGN [19]. In
our experiments, the number of RPS increased in differentiat-
ed as well as in co-cultured BEC (Fig. 3). The enrichment of
RPS, particularly in the processes (Table 1), can be involved in
lateral tubular trafficking at overlapping parts, as suggested by
EM studies [73]. To study RPS, we labelled VPS35 the non-
variable component of the retromer complex [19]. However,
the mammalian retromer shows variability in composition of
SNX-BAR dimer and VPS26 [17]. Therefore, we investigated
gene and protein expression profile of the subunits of these
retromers (Fig. 6a and b). At gene expression level, the most
prominent differences were observed in SNX1 and SNX6
(Fig. 6a and Table S3). SNX1 protein was detected only in
co-cultured BEC (Fig. 6b), while SNX6-positive structures
showed a different trend than the VPS35-positive ones
(Fig. 6e). Our data points out that the differentiation factors
and astrocytes influence the various types of retromer in a
separate and not a general way. In the retromer complex, the
core complex (VPS35-VPS26-VPS35) is essential for the
cargo/receptor selection, while the interchangeable SNX-
BAR subunit is responsible to direct the subcellular trafficking
toward different destinations [17]. Thus, it is likely that the
different sets of retromer subtypes direct retrograde recep-
tors in different directions in co-cultured BEC. For instance,
the SNX1-retromer promotes E-cadherin trafficking to the
TGN, from where it will be recycled to the plasma mem-
brane of epithelial cells [74]. Since astrocytes are known to
enhance localisation of E-cadherin to cell borders during co-
culture [22], we suggest that SNX1-retromer is also in-
volved in this process at the BBB. Further investigation is
needed to support this hypothesis and to revile if SNX1-
retromer guides only the E-cadherin or also the vascular
endothelial specific VE-cadherin. Our observations on the
retromer can be particularly interesting for receptor-
mediated transcytosis in the light of a recent finding where
the retromer-transported mannose-6-phosphate receptor
was described as a potential target for receptor-mediated
Fig. 5 Morphological alterations of the vesicles: shape and area. The
circularity factor (left panel) describes the shape of adjacent vesicles.
Values are represented as mean ± SEM, n = 9. The area of the vesicles is
shown with a box diagram (right panel); box represents 25 and 75
percentiles. The horizontal line represents the median, n = 9. Statistical
analysis; difference was analysed by one-way ANOVA followed by
Tukey’s post hoc test. Values were considered statistically significant at
* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001
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delivery of pharmaceutical antibodies in BEC [38]. Taken
together, our present and previous [38] works confirm that
the retromer and the retrograde receptors are present in BEC
(Table S3). We have shown that the retromer is upregulated
and different compositions of retromer subtypes are present in
co-cultured BEC. These observations can highlight retrograde
Fig. 6 Expression analysis of adaptor proteins in the BEC. a Changes in
gene expression level of co-cultured BEC for selected trafficking-related
genes. The table shows the fold change (2−ΔΔCT values) in gene
expression level of co-cultured BEC normalised to the gene expression
level of the control (2−ΔΔCT) and measured by RT-qPCR method. 1
equals no change, < 1 = decrease, > 1 = increase in gene expression
compared to control, n = 9. Statistics were carried out with unpaired t
test with Welch’s correction analysis. NE; not expressed. +; AP1M2 in
porcine kidney homogenate. b Western blot for protein expression level
of selected adaptor proteins in BEC in vitro. Intensity values of proteins
were normalised toβ-actin and then compared to the control (100%), n =
12. c Protein ratio of pERK1/2 and ERK1/2 by WB. Values expressed as
mean ± SEM, n = 12. WB of one representative sample is shown in the
right panel. Values were considered being statistically significant at
*p < 0.05. d Immunofluorescence for SNX6-RPS. Green staining
indicates SNX6-RPS. The junctions of BEC were marked with
antibody against tight junction protein, ZO1. For staining of nuclei
Hoescht 32528 was used. Scale bar: 10 μm. Number of vesicles were
normalised to the control (100%). e Change in the number of SNX6-
positive retromer structures (SNX6-RPS) normalised to the total
number of RPS (Vps35 positive) in control BEC (100%). All values are
expressed as mean ± SEM, n = 9. Difference was analysed by one-way
ANOVA followed by Tukey’s post hoc test. Values were considered
being statistically significant at +++ p ≤ 0.001 compared to the SNX6-
RPS control * p ≤ 0.05 compared to the Total-RPS control. ns; not
significant
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receptors as efficient targets for drug transport toward the
brain.
Trafficking among the structures of the endo-lysosomal
system is guided by specific adaptor proteins such as adaptins
[57]. The gene expression pattern of adaptins in BEC (Fig. S3)
was similar to the adaptin copy number described in HeLa
cells [56]. In polarised cells like epithelial cells and neurons,
cell-specific isotopes of adaptors developed in evolution to
ensure delivery of membrane components to the appropriate
plasma membrane domain [57]. Since our current understand-
ing of trafficking in BEC ismainly based on assumptions from
studies of other polarised cells, we have investigated the ex-
pression of adaptin isoforms. In addition to the ubiquitously-
expressed AP1-μ1A, polarised epithelial cells express the
AP1-μ1B variant, which supports delivery of proteins, includ-
ing β-catenin and TfR, to the basolateral domain [20].
Interestingly, the gene of AP1-μ1B (AP1M2) was not
expressed in porcine BEC (Fig. 6a and Table S3) indicating
that transport of receptor to the basal and lateral membrane in
BEC needs sorting machinery different from that of epithelial
cells. In order to further support the cell-specific expression of
AP1M2, future studies should include BEC also from other
species. Furthermore, we found that the previously known as
neuron-specific gene of AP3-μ3B (AP3M2) [75] is expressed
in BEC (Fig. 6a and Table S3). AP3-3μB is known to be
responsible for synaptic vesicle formation [75]. Its role in
BEC has not been described yet. Although contamination by
neurons cannot be completely excluded, it is highly unlikely,
as only cells expressing P-glycoprotein (like BEC) will sur-
vive the treatment with puromycin [69] during our BEC puri-
fication [76]. Our finding on distinctively expressed adaptor
proteins in receptor trafficking might be useful to verify brain
endothelial-specific transport machinery also in the currently
developed human BBBmodels from induced pluripotent stem
cells [77, 78]. Distinctive expression of AP1M1 and AP3M2
indicates for the first time that polarised trafficking in BEC
differs from that of epithelia and therefore needs to be specif-
ically examined.
For our investigation, we used porcine BEC, since their
morphology and physiology are more similar to the human
than rodent BEC [79]. Therefore, porcine BEC are highly
suitable for the development of drug delivery strategies to
future human applications. We investigated the effects of as-
trocytes and differentiation factors on the endo-lysosomal sys-
tem of BEC. To reveal the effect of differentiation factors
separately, we compared co-cultured BEC with monoculture
of differentiated BEC. The differentiation mixture alone did
not have such an influence on the vesicular system of BEC as
it did in the presence of astrocytes. These results underline the
importance of using co-culture models in in vitro studies
where the vesicular system of BEC is in focus, such as recep-
tor trafficking and drug delivery. We used cross-species co-
culture model, since combination of porcine and rat astrocyte
is one of the most widespread and accepted setup for in vitro
BBB models based on primary cells [3]. A recent study has
compared rat versus porcine astrocytes in co-culture with por-
cine BEC and no differences in BEC’s barrier properties were
reported [36], although effects on the transcellular or vesicular
transport properties between these two models cannot be ex-
cluded. It should be analysed further in upcoming studies.
Furthermore, it will be interesting to include pericytes in co-
culture systems in follow-up studies, as these have been dem-
onstrated to be involved in regulating transcytosis [80].
Particularly, peryicytes mediated downregulation of
MFSD2A has been elegantly demonstrated to increase BEC
transcytosis, as MFSD2A dramatically inhibits vesicular
transcytosis across the BBB [81].
In conclusion, our study is the first to investigate the effects
of astrocytes on the endo-lysosomal system in BEC by clas-
sifying the vesicles and transport routes with specific markers
and adaptor proteins. We show that the expression of specific
adaptor proteins in BEC differs in subtle ways from that of
polarised epithelial cells. Data from our study may help im-
proving to design strategies to traverse the BBB more
intelligently.
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